Pim kinase inhibitors: a survey of the patent literature

Expert Opinion on Therapeutic Patents
Tina Morwick

Abstract

Pim kinases have recently emerged as targets of interest in oncology and immune regulation. Ongoing studies have identified a role for these proteins in cell survival and proliferation, both functionally and mechanistically, and overexpression has been observed in a number of human cancers and inflammatory states. This report reviews the patent literature for Pim kinase inhibitors identified from a search of the Thomson patent databases from 1970 through July 2009. Full analyses are provided for publications reporting Pim kinases as primary targets, and a cursory description is given for those disclosing Pim as one of a limited number of secondary targets. Readers will gain an overview of the various inhibitor series including coverage, potency, selectivity, protein binding features and therapeutic focus, and an appreciation for which scaffolds and structural features have been most highly exploited. A greater understanding of pathological mechanisms for Pim kinases has stimulated the recent development of a variety of inhibitor classes with one compound advancing into the clinic earlier this year. Ongoing studies will help define applications for these inhibitors in the treatment of Pim-associated human diseases.

References

Oct 11, 1993·Nucleic Acids Research·P W LairdM Hooper
Dec 31, 1997·Molecular and Cellular Biology·A KelekarC B Thompson
Nov 7, 1998·Biochimica Et Biophysica Acta·D BaytelJ Don
Dec 26, 2001·Chemical Reviews·A J Bridges
Jun 14, 2002·Trends in Cell Biology·Khalil AhmedClaude Cochet
Aug 30, 2002·Blood·Jaime O ClaudioA Keith Stewart
Dec 10, 2002·Science·G ManningS Sudarsanam
Jul 19, 2003·Genes & Development·Casey J FoxCraig B Thompson
Sep 5, 2003·The Journal of Biological Chemistry·Bin YanMichael Lilly
Mar 30, 2004·Nature Reviews. Drug Discovery
Jul 21, 2004·The Prostate·Alexander ValdmanLars Egevad
Nov 5, 2004·The Journal of Biological Chemistry·Kevin C QianBennett Farmer
Jan 12, 2005·The Journal of Experimental Medicine·Casey J FoxCraig B Thompson
Jan 20, 2005·The Journal of Biological Chemistry·Marc D JacobsKumkum Saxena
Feb 8, 2005·The International Journal of Biochemistry & Cell Biology·Malte Bachmann, Tarik Möröy
Feb 16, 2005·Nature Biotechnology·Miles A FabianDavid J Lockhart
Oct 4, 2005·The Journal of Clinical Investigation·Ravi Amaravadi, Craig B Thompson
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
Dec 29, 2005·Angewandte Chemie·Judit E DebreczeniEric Meggers
Mar 2, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Kevin C QianBennett Farmer
Aug 3, 2006·Nature Reviews. Drug Discovery·Sandrine FaivreEric Raymond
Jan 16, 2007·Molecular Cancer Therapeutics·Sheldon HolderMichael B Lilly
Jan 26, 2007·Bioorganic & Medicinal Chemistry Letters·I Wayne CheneyJim Z Wu
Jul 20, 2007·Bioorganic & Medicinal Chemistry·Sheldon HolderMilton L Brown
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Oleg FedorovStefan Knapp
Feb 23, 2008·Journal of Medicinal Chemistry·Albert C PierceCameron Stuver-Moody
Jul 1, 2008·The Biochemical Journal·Mario A PaganoLorenzo A Pinna
Aug 2, 2008·Bioorganic & Medicinal Chemistry Letters·Cynthia M ShaferAnnette Walter
Dec 17, 2008·Journal of Medicinal Chemistry·Zuping XiaCharles D Smith

❮ Previous
Next ❯

Citations

Aug 24, 2011·The Journal of Experimental Medicine·Jonathan H SchatzHans-Guido Wendel
Jul 22, 2010·Molecular Cancer Research : MCR·Marina ZemskovaAndrew S Kraft
Jan 15, 2015·Future Medicinal Chemistry·Bich Thuy LeShudong Wang
Oct 18, 2013·Expert Opinion on Therapeutic Patents·Gubbi M AruneshVellarkad N Viswanadhan
Jan 29, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Wanyeon KimBuHyun Youn
Oct 9, 2012·Biochemical Pharmacology·Carmen Blanco-Aparicio, Amancio Carnero
Jan 24, 2012·Bioorganic & Medicinal Chemistry Letters·Joaquín PastorMarco Mazzorana
Sep 29, 2011·Bioorganic & Medicinal Chemistry Letters·Gisele A NishiguchiMika Lindvall
May 24, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Methvin IsaacJan Jongstra
Aug 11, 2010·Biochemical Pharmacology·Lisa S ChenVarsha Gandhi
Oct 16, 2015·Bioorganic & Medicinal Chemistry Letters·Huiyong HuAleksandr Kolesnikov
Apr 12, 2013·Medicinal Research Reviews·Maja Narlik-GrassowAmancio Carnero
Aug 20, 2016·Journal of Enzyme Inhibition and Medicinal Chemistry·Bassem H Naguib, Hala B El-Nassan
Mar 19, 2013·Bioorganic & Medicinal Chemistry Letters·Laurent GavaraPascale Moreau
Oct 22, 2013·Bioorganic & Medicinal Chemistry·Francesco CasuscelliEduard R Felder
Jan 21, 2015·Bioorganic & Medicinal Chemistry Letters·Ryan P WurzAndrew S Tasker
Sep 23, 2011·Blood·Cristina Gómez-AbadMiguel A Piris
Apr 30, 2013·Bioorganic & Medicinal Chemistry Letters·Xiaojing WangAllen J Ebens
Jun 16, 2015·PloS One·Niina M SantioPäivi J Koskinen
Aug 29, 2012·Journal of Medicinal Chemistry·Denis DryginDavid M Ryckman
Jun 6, 2014·ACS Medicinal Chemistry Letters·Matthew T BurgerPablo D Garcia
Oct 23, 2016·Bioorganic & Medicinal Chemistry Letters·Ryan P WurzHui-Ling Wang
Jan 18, 2017·Journal of Enzyme Inhibition and Medicinal Chemistry·Bassem H NaguibTamer M Abdelghany
Dec 15, 2010·Nature Reviews. Cancer·Martijn C NawijnAnton Berns
Mar 22, 2019·Physical Chemistry Chemical Physics : PCCP·Xiaohui Wang, Zhaoxi Sun
Dec 31, 2016·Pharmacological Reviews·David O BatesLucy F Donaldson
Sep 25, 2017·Oncotarget·Manuel-Pedro Jiménez-GarcíaAmancio Carnero
Dec 3, 2016·Scientific Reports·Manuel Pedro Jiménez-GarcíaAmancio Carnero
Jan 30, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pablo D GarciaMatthew T Burger
Apr 29, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Riet van der MeerMeejeon Roh
Nov 1, 2020·Bioorganic & Medicinal Chemistry·Camilo E QuevedoAngela J Russell
Feb 9, 2012·ACS Medicinal Chemistry Letters·Mustapha HaddachDavid M Ryckman
Aug 30, 2021·Biochimica Et Biophysica Acta. General Subjects·Aanchal RathiMd Imtaiyaz Hassan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.